Peer-to-Peer Podcast

CME/CE Information

LEARNING OBJECTIVE

Upon completion of the activity, participants should be able to:

• Distinguish evidence-based therapeutic options for the management of POI

FACULTY

Tong Joo (TJ) Gan, MD, FRCA, FFARCS(I)
Professor of Anesthesiology
Vice Chairman Clinical Research
Duke University Medical Center
Durham, North Carolina

Michael D. Kraft, PharmD
Clinical Assistant Professor
University of Michigan College of Pharmacy
 
Clinical Coordinator
University of Michigan Health System
Department of Pharmacy Services
Ann Arbor, Michigan

Steven D. Wexner, MD, FACS, FRCS, FRCSEd
Chief Academic Officer
Cleveland Clinic Florida
Weston, Florida

SPONSOR

This activity is sponsored by The France Foundation.

TARGET AUDIENCE

This activity is intended for colon/rectal surgeons, general surgeons, anesthesiologists, health-system pharmacists, medical/surgical nurses, and other health care professionals who manage postoperative ileus (POI).

STATEMENT OF NEED

Postoperative ileus (POI) is a common but underrecognized problem in patients undergoing bowel resection and other major abdominal surgeries. POI can become prolonged and lead to longer hospital stays, patient discomfort and a number of serious postsurgical complications. Prevention and treatment of POI requires a multimodal management approach due to the diverse underlying physiological factors that contribute to this disorder. The surgical team, including surgeons, nurses, and pharmacists, are largely responsible for carrying out this multimodal strategy and thus have a critical need for current education on the management of POI.

ACCREDITATION STATEMENT

The France Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION

Physicians
The France Foundation designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses
Nurses who are certified by the American Nurses Credentialing Center (ANCC) may utilize activities that are certified by ACCME-accredited providers toward their requirement for certification renewal by the ANCC. A certificate of attendance will be provided by The France Foundation, an ACCME- accredited provider.

RESOLUTION OF CONFLICTS OF INTEREST

In accordance with the ACCME Standards for Commercial Support of CME, The France Foundation will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

DISCLOSURE

It is the policy of The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, content reviewers, and staff participating in this activity have disclosed to the participants any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The France Foundation has identified and resolved any and all conflicts of interest prior to the release of this activity.

Activity Staff Disclosures

The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

Faculty Disclosure

The following faculty have indicated they have relationships with industry to disclose relative to the content of this CME activity:

• Tong Joo (TJ) Gan, MD, FRCA, FFARCS(I), has received grants/research support from Baxter, MGI, and Schering-Plough. He has received honoraria from Baxter, Edwards Lifesciences, Fresenius, and GlaxoSmithKline.
• Michael D. Kraft, PharmD, has served as a consultant for Adolor, GlaxoSmithKline, and Wyeth. He has received honoraria from Adolor and GlaxoSmithKline.
• Steven D. Wexner, MD, FACS, FRCS, FRCSEd, has received grants/research support from Covidien and Karl Storz Endoscopy America, Inc. He has served as a consultant for Century Medical (Japan), Covidien, CR Bard, EZ Surgical, Incontinence Devices, Inc, Karl Storz Endoscopy America, Inc, Signalomics GmbH, and SurgRx. He has stock options in CRH Medical, EZ Surgical, Intuitive Surgical, Neatstitch, Power Medical Interventions, and SurgRx. He has received honoraria from Adolor, GlaxoSmithKline, and Power Medical Interventions. He has received other financial or material support from Covidien.

UNAPPROVED USE DISCLOSURE

The France Foundation requires CME faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

COMMERCIAL SUPPORT ACKNOWLEDGMENT

This activity is supported by an educational grant from Adolor and GlaxoSmithKline.

DISCLAIMER

The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation, Adolor, and GlaxoSmithKline assume no liability for the information herein.

COPYRIGHT INFORMATION

Copyright © 2009 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

• The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
• Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.

PRIVACY POLICY

The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

Additional information regarding The France Foundation's Privacy Policy can be viewed at http://www.francefoundation.com/privacy.

CONTACT INFORMATION

If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.